Natural Alternatives International (NAII) Competitors $3.41 -0.01 (-0.41%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. PLRX, ZURA, EPIX, QNCX, SRZN, INCR, IMMX, ABOS, IMUX, and GNTAShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Pliant Therapeutics (PLRX), Zura Bio (ZURA), ESSA Pharma (EPIX), Quince Therapeutics (QNCX), Surrozen (SRZN), InterCure (INCR), Immix Biopharma (IMMX), Acumen Pharmaceuticals (ABOS), Immunic (IMUX), and Genenta Science (GNTA). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Its Competitors Pliant Therapeutics Zura Bio ESSA Pharma Quince Therapeutics Surrozen InterCure Immix Biopharma Acumen Pharmaceuticals Immunic Genenta Science Natural Alternatives International (NASDAQ:NAII) and Pliant Therapeutics (NASDAQ:PLRX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation. Do insiders & institutionals hold more shares of NAII or PLRX? 32.4% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 97.3% of Pliant Therapeutics shares are owned by institutional investors. 20.9% of Natural Alternatives International shares are owned by company insiders. Comparatively, 6.4% of Pliant Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is NAII or PLRX more profitable? Pliant Therapeutics has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.56%. Natural Alternatives International's return on equity of -10.34% beat Pliant Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.56% -10.34% -5.19% Pliant Therapeutics N/A -67.56%-52.54% Do analysts recommend NAII or PLRX? Pliant Therapeutics has a consensus target price of $13.31, suggesting a potential upside of 893.47%. Given Pliant Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Pliant Therapeutics is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Pliant Therapeutics 0 Sell rating(s) 12 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer NAII or PLRX? In the previous week, Pliant Therapeutics had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 2 mentions for Pliant Therapeutics and 1 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 1.91 beat Pliant Therapeutics' score of 1.81 indicating that Natural Alternatives International is being referred to more favorably in the media. Company Overall Sentiment Natural Alternatives International Very Positive Pliant Therapeutics Very Positive Which has more volatility & risk, NAII or PLRX? Natural Alternatives International has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, Pliant Therapeutics has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Which has better valuation & earnings, NAII or PLRX? Natural Alternatives International has higher revenue and earnings than Pliant Therapeutics. Natural Alternatives International is trading at a lower price-to-earnings ratio than Pliant Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$113.80M0.19-$7.22M-$1.39-2.47Pliant Therapeutics$1.58M52.06-$210.30M-$3.61-0.37 SummaryPliant Therapeutics beats Natural Alternatives International on 8 of the 15 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.20M$2.44B$5.57B$9.31BDividend YieldN/A1.79%4.23%4.03%P/E Ratio-2.479.1828.6119.73Price / Sales0.19575.37411.30174.40Price / CashN/A164.3436.0257.96Price / Book0.264.698.235.67Net Income-$7.22M$30.99M$3.23B$257.79M7 Day Performance0.15%0.61%0.01%0.54%1 Month Performance-0.87%7.94%5.63%8.86%1 Year Performance-39.08%-5.47%26.55%14.22% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International1.4601 of 5 stars$3.43+0.3%N/A-39.3%$21.20M$113.80M-2.47290Positive NewsPLRXPliant Therapeutics4.4518 of 5 stars$1.18-6.3%$13.31+1,028.2%-89.5%$77.35M$1.58M-0.3390ZURAZura Bio3.075 of 5 stars$1.10-2.7%$14.33+1,203.0%-64.8%$77.26MN/A-1.573Positive NewsGap UpEPIXESSA Pharma1.0573 of 5 stars$1.70-2.3%$2.00+17.6%-66.7%$77.24MN/A-2.7050QNCXQuince Therapeutics3.0548 of 5 stars$1.63+1.2%$8.00+390.8%+130.7%$73.21MN/A-1.1760News CoverageSRZNSurrozen2.7519 of 5 stars$8.35-0.1%$38.50+361.1%-10.0%$71.58M$10.65M-0.3380Positive NewsINCRInterCure0.6724 of 5 stars$1.50-3.8%N/A-37.4%$71.09M$238.85M0.00350News CoveragePositive NewsHigh Trading VolumeIMMXImmix Biopharma3.5571 of 5 stars$2.62+2.7%$7.00+167.2%+35.3%$71.09MN/A-3.749ABOSAcumen Pharmaceuticals3.0011 of 5 stars$1.16flat$6.33+446.0%-54.7%$70.26MN/A-0.6020News CoverageIMUXImmunic2.4802 of 5 stars$0.77+5.2%$11.60+1,416.3%-38.7%$69.68MN/A-0.6270GNTAGenenta Science2.6015 of 5 stars$3.98+4.7%$25.00+528.1%+10.0%$69.50MN/A0.007Gap Up Related Companies and Tools Related Companies Pliant Therapeutics Competitors Zura Bio Competitors ESSA Pharma Competitors Quince Therapeutics Competitors Surrozen Competitors InterCure Competitors Immix Biopharma Competitors Acumen Pharmaceuticals Competitors Immunic Competitors Genenta Science Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAII Stock Alerts